Amniotic-fluid metabolomics identifies phospholipid remodeling as a metabolic signature of intrauterine exposure in pregnancies with polycystic ovary syndrome.
- DOI
- 10.3389/fendo.2026.1904695
- Published
- 2026
- Container
- Frontiers in endocrinology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fendo.2026.1904695,
title = {Amniotic-fluid metabolomics identifies phospholipid remodeling as a metabolic signature of intrauterine exposure in pregnancies with polycystic ovary syndrome.},
author = {Wu S and Shi J and He C and Chen J and Guo Q and Li S and Tong J and Chen Q and Yan Z and Du J and Yu X and Lin K and Tan Y},
year = {2026},
journal = {Frontiers in endocrinology},
doi = {10.3389/fendo.2026.1904695},
url = {https://doi.org/10.3389/fendo.2026.1904695}
}RIS
TY - JOUR TI - Amniotic-fluid metabolomics identifies phospholipid remodeling as a metabolic signature of intrauterine exposure in pregnancies with polycystic ovary syndrome. AU - Wu S AU - Shi J AU - He C AU - Chen J AU - Guo Q AU - Li S AU - Tong J AU - Chen Q AU - Yan Z AU - Du J AU - Yu X AU - Lin K AU - Tan Y PY - 2026 JO - Frontiers in endocrinology DO - 10.3389/fendo.2026.1904695 UR - https://doi.org/10.3389/fendo.2026.1904695 ER -
APA
S, W., J, S., C, H., J, C., Q, G., S, L., J, T., Q, C., Z, Y., J, D., X, Y., K, L., & Y, T. (2026). Amniotic-fluid metabolomics identifies phospholipid remodeling as a metabolic signature of intrauterine exposure in pregnancies with polycystic ovary syndrome.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1904695
Source records
- pubmed · retrieved 2026-09-26T11:11:51.392Z
- europe-pmc · retrieved 2026-09-26T11:11:51.405Z
- doaj · retrieved 2026-09-26T11:11:51.386Z